HomeComparePMNV vs MRK

PMNV vs MRK: Dividend Comparison 2026

PMNV yields 0.00% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $38.0K in total portfolio value
10 years
PMNV
PMNV
● Live price
0.00%
Share price
$24.93
Annual div
$0.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.7K
Annual income
$0.35
Full PMNV calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — PMNV vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPMNVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PMNV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PMNV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PMNV
Annual income on $10K today (after 15% tax)
$0.30/yr
After 10yr DRIP, annual income (after tax)
$0.30/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,596.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PMNV + MRK for your $10,000?

PMNV: 50%MRK: 50%
100% MRK50/50100% PMNV
Portfolio after 10yr
$38.7K
Annual income
$5,057.06/yr
Blended yield
13.07%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PMNV
No analyst data
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PMNV buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPMNVMRK
Forward yield0.00%2.81%
Annual dividend / share$0.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$19.7K$57.7K
Annual income after 10y$0.35$10,113.78
Total dividends collected$3.00$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PMNV vs MRK ($10,000, DRIP)

YearPMNV PortfolioPMNV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,700$0.35$11,213$373.04$513.00MRK
2$11,450$0.35$12,667$512.06$1.2KMRK
3$12,252$0.35$14,439$708.14$2.2KMRK
4$13,110$0.35$16,640$988.16$3.5KMRK
5$14,028$0.35$19,432$1,394.07$5.4KMRK
6$15,010$0.35$23,057$1,992.90$8.0KMRK
7$16,061$0.35$27,889$2,894.79$11.8KMRK
8$17,185$0.35$34,518$4,286.29$17.3KMRK
9$18,389$0.35$43,912$6,494.35$25.5KMRK
10$19,676$0.35$57,714$10,113.78$38.0KMRK

PMNV vs MRK: Complete Analysis 2026

PMNVStock

PMNV uses FLEX options to match the price returns of SPDR S&P 500 ETF Trust (SPY), up to a predetermined upside cap of at least 3%, while seeking to provide the maximum available buffer of 100% over a one-year period starting in November. At the end of the target outcome period, the upside cap and downside buffer for the new target outcome period are reset to prevailing market conditions. If the fund is not able to set the maximum buffer against 100% of the losses, then it would seek to adjust the cap. Likewise, if the fund cannot set a cap of at least 3%, then it would seek to adjust the maximum buffer instead. To achieve the target outcomes sought by the fund for a target outcome period, an investor must hold fund shares for that entire target outcome period.

Full PMNV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PMNV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PMNV vs SCHDPMNV vs JEPIPMNV vs OPMNV vs KOPMNV vs MAINPMNV vs JNJPMNV vs ABBVPMNV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.